+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection



Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection



Infection and Immunity 67(6): 3019-3025



We sought to assess the degree of cross-protective immunity in a mouse model of chlamydial genital tract infection. Following resolution of genital infection with the mouse pneumonitis (MoPn) biovar of Chlamydia trachomatis, mice were challenged intravaginally with either MoPn or human serovar E or L2. The majority of animals previously infected with MoPn were solidly immune to challenge with either of the two human biovars. Surprisingly, approximately 50% of animals became reinfected when homologously challenged with MoPn, although the secondary infection yielded significantly lower numbers of the organism isolated over a shorter duration than in the primary infection. Primary infection with serovar E also protected against challenge with MoPn or serovar L2, although the degree of immune protection was lower than that resulting from primary infection with MoPn. Blast transformation and assessment of delayed-type hypersensitivity indicated that mice previously infected with either human or murine biovars produced broadly cross-reactive T cells that recognized epitopes of either murine or human biovars of C. trachomatis. Immunoblotting demonstrated that primary MoPn infection produced immunoglobulin G (IgG) antibody to antigens of MoPn as well as at least three distinct antigenic components of human serovar E, one of which was identical in molecular weight to the major outer membrane protein (MOMP). Primary infection with serovar E produced IgG antibody reactive against serovar E but not MoPn MOMP and against at least one ca. 60-kDa protein of both chlamydial strains. Our results indicate that primary genital infection of mice with murine C. trachomatis induces immunity against challenge with either of two human biovars.

(PDF emailed within 1 workday: $29.90)

Accession: 011199767

Download citation: RISBibTeXText

PMID: 10338514


Related references

Prior genital tract infection with the mouse biovar of Chlamydia trachomatis protects against a challenge infection with human serovar E. Abstracts of the General Meeting of the American Society for Microbiology 98: 219, 1998

The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis. Vaccine 19(28-29): 4061-4071, 2001

Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice. Bmc Infectious Diseases 5: 105, 2005

Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: Serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection. Vaccine 13(11): 1023-1032, 1995

Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge. Vaccine 15(5): 575-582, 1997

Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-membrane protein. Journal of General Microbiology 138 Pt 8: 1707-1715, 1992

Intravaginal Chlamydia trachomatis Challenge Infection Elicits TH1 and TH17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage. Plos One 11(9): E0162445, 2017

Murine Models of Chlamydia trachomatis Genital Tract Infection: Use of Mouse Pneumonitis Strain versus Human Strains. Infection and Immunity 68(12): 7209-7211, 2000

Murine models of Chlamydia trachomatis genital tract infection: use of mouse pneumonitis strain versus human strains. Infection and Immunity 68(12): 7209-7211, 2001

Murine model of ocular infection by a human biovar of Chlamydia trachomatis. Investigative Ophthalmology & Visual Science 36(10): 1976-1987, 1995

Murine models of Chlamydia trachomatis genital tract infection Use of mouse pneumonitis strain versus human strains Authors reply. Infection & Immunity 68(10): 6038-6040, 2000

Genital-tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis. British Journal of Experimental Pathology 63(5): 539-546, 1982

Ocular infection of inbred mice with a human biovar of Chlamydia trachomatis. Abstracts of the General Meeting of the American Society for Microbiology 93(0): 122, 1993

Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infection and Immunity 66(9): 4030-4035, 1998

Chlamydia trachomatis genital tract infection in gene knockout mice. Journal of Cellular Biochemistry Supplement 0(21B): 254, 1995